No Data
XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2024
XORTX Therapeutics Stock Falls After Pricing $1.5M Capital Raise
XORTX Enters Securities Purchase Agreements With Institutional Investors For Purchase And Sale Of 810,810 Shares At $1.85/Common Share
XORTX Therapeutics Brief: Announcing Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement
XORTX Announces Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement
XORTX Initiates Precision Medicine Program
No Data